Outcome of Board Meeting

Date: 14th August, 2026 National Stock Exchange of India Ltd., Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051. Stock Code: VAISHALI Sub: Outcome of Board Meeting held on Friday, 14th August, 2026 Dear Sir/Madam, In terms of Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 ("the Listing Regulations"), we wish to inform you that, Board of Directors of the Company, at its meeting held today i.e. 14th August, 2026 has inter-alia considered and approved the following: 1. Unaudited Financial Results along with Limited Review Report as submitted by the statutory auditor of the Company for the First Quarter Ended 30th June, 2026; Accordingly, the Unaudited Financial Results for the First Quarter Ended 30th June, 2026 along with Limited Review Report are attached herewith as “Annexure I”. 2. Annual Report and Director’s Report of the Company for the Financial Year 2025-26; 3. Notice convening the 19th Annual General Meeting of the Company, proposed to be held on Thursday, 24th September, 2026, through Video Conferencing (VC) or Other Audio-Visual Means (OAVM). 4. The Register of Members and Share transfer books of the Company will remain closed from Friday, 18th September, 2026 to Thursday, 24th September, 2026 (both days inclusive) for the purpose of the 19th Annual General Meeting of the Company; 5. Appointment of HD & Associates, Company Secretaries as a Scrutinizer to conduct remote e-voting of 19th Annual General Meeting; The meeting of the Board commenced at 2:30 P.M. and concluded at 3:40 P.M. Kindly take the above on record. Thanking You, Yours Faithfully, For Vaishali Pharma Limited Vishwa Mekhia Company Secretary Cum Compliance Officer